The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus long terminal repeat

Virus Res. 1997 Oct;51(2):203-12. doi: 10.1016/s0168-1702(97)00094-4.

Abstract

The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus (FIV) long terminal repeat (LTR) were examined by gel-mobility-shift assays using oligonucleotides designed to represent putative AP-1 or ATF motif from the FIV LTR. Infection with FIV led to less nuclear proteins binding to the AP-1 and ATF sites, suggesting that proteins binding to the sites were consumed or suppressed by FIV-replication in FIV-infected cells. Nuclear proteins that bind to the AP-1 or ATF site were examined by using extracts from Crandell feline kidney (CRFK) cells treated with TPA (a phorbol ester; a strong activator of protein kinase C) or forskolin (an inducer of cyclic-AMP), or infection with feline herpesvirus type 1 (FHV-1). Although TPA or forskolin treatment moderately increased the level of both proteins that bound to AP-1 and ATF sites, FHV-1 infection markedly changed the protein-binding patterns of the sites. Furthermore, FHV-1-induced proteins that bind adjacent to the transcriptional initiation site of FIV promoter were also observed in FHV-1-infected CRFK cells, suggesting that the FHV-1-induced-proteins affects the transcription of FIV through the AP-1, ATF and leader sequences.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Cats
  • Cell Line
  • Colforsin / pharmacology*
  • Herpesviridae / physiology*
  • Immunodeficiency Virus, Feline / genetics*
  • Nuclear Proteins / drug effects
  • Nuclear Proteins / metabolism*
  • Peptide Chain Initiation, Translational
  • Repetitive Sequences, Nucleic Acid*
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transcription, Genetic

Substances

  • Nuclear Proteins
  • Colforsin
  • Tetradecanoylphorbol Acetate